Component
Human cardiac function in primary carnitine deficiency
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
In a reported patient with homozygous SLC22A5-associated primary carnitine deficiency and a cardiac presentation, cardiac function remained normal during 14 years of oral carnitine treatment.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Single human case and long-term follow-up.
- limitations
- One case, no untreated comparator; not proof of general cardiovascular benefit.
- nutrient_topic
- L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
- plain_language
- Treating a confirmed transport disorder can have a different role from general supplementation.
- primary_references
- Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26030785/ · DOI 10.1515/jpem-2014-0528
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 82–88
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Single human case and long-term follow-up. · source_derived_draft · unverified_draft
## l-carnitine-primary-heart Treating a confirmed transport disorder can have a different role from general supplementation. In a reported patient with homozygous SLC22A5-associated primary carnitine deficiency and a cardiac presentation, cardiac function remained normal during 14 years of oral carnitine treatment. Model: Single human case and long-term follow-up. Limitations: One case, no untreated comparator; not proof of general cardiovascular benefit. Evidence access: Primary abstract Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up. · 2015 · https://pubmed.ncbi.nlm.nih.gov/26030785/ · DOI 10.1515/jpem-2014-0528
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.